Kornelia Mikuła awarded the LifeArc Knowledge Transfer Innovation Fellowship
Kornelia Mikuła, Head of the Technology Transfer Office at IIMCB, has been awarded the highly prestigious LifeArc Knowledge Transfer Innovation Fellowship. LifeArc is a self-funded, non-profit medical research organization with a mission to transform scientific discoveries into real-world solutions. The fellowship equips participants with expertise and practical skills to develop their competencies in technology transfer. The program offers a comprehensive curriculum that integrates training with networking, mentorship, and hands-on experience. This is the first time the fellowship has been awarded to a fellow associated with a Polish institute.
”I am truly honored to be awarded the LifeArc Knowledge Transfer Innovation Fellowship. It is a great opportunity to receive formal training by the best in the technology and knowledge transfer field including AUTM, ASTP and LifeArc experts. The most important part for me are the mentoring and networking, as these are crucial for establishing a strong foundation for a successful research valorization. I am sure that the fellowship and all that it brings will be a major steppingstone not only in my career, but also in IIMCB’s journey to bring great scientific solutions to benefit the whole society”, says Kornelia Mikuła.
The Technology Transfer Office (TTO) at the IIMCB, headed by Kornelia, has been created as one of the pillars of the RACE project. It is committed to support the Institute’s research in identifying and developing scientific discoveries that can be turned into solutions for patients and society. IIMCB’s efforts to become a unique Center of Excellence is supported by EU-LIFE working groups and the Commercialization Advisory Committee (CAC), composed of international experts in science valorization, our advanced partners from VIB and the University of Edinburgh.
As part of a one-year fellowship program at LifeArc, Kornelia will receive personalized mentorship, an access to an extensive network of technology transfer professionals, and a membership to both AUTM and ASTP. Last but not least, she will represent IIMCB in a top-notch international forum, distinguishing the institute in the fields of innovation and technology commercialization.
Dr. Anji Miller, who leads the LifeArc Fellowship programs, adds, "The LifeArc Knowledge Transfer Innovation program helps ensure that future scientific discoveries reach patients and improve lives. Our fellows receive world-class training, mentoring, and access to resources. As trained technology transfer professionals, they will help transfer promising science from the lab bench to the patient. We are pleased to welcome Kornelia and our other successful LifeArc Knowledge Transfer Innovation 2024 fellows to the program, and we look forward to supporting them in the next step of their careers."
Since its inception in 2017, the fellowship has helped over 72 individuals from 11 European countries excel in skills and knowledge within the innovation sector. This year, 17 fellows from seven countries are participating in the program. For further details, please refer to the following link: https://www.lifearc.org/careers/early-careers/knowledge-transfer-innovation-fellowship/
About LifeArc
LifeArc is a self-funded, not-for-profit medical research charity. It takes scientific ideas out of the lab and helps turn them into medical breakthroughs that can be life-changing for patients. LifeArc has been doing this for more than 25 years, resulting in five licensed medicines, including the cancer drug pembrolizumab (Keytruda), lecanemab for Alzheimer’s (Leqembi), and a diagnostic for antibiotic resistance. The teams at LifeArc are experts in drug and diagnostics discovery, technology transfer, and intellectual property. Their work focuses on translational science—bridging the gap between academic research and clinical development by providing funding, research, and expert knowledge, all with a clear and unwavering commitment to positively impacting patients' lives.
Find out more about LifeArc work on www.lifearc.org or follow on LinkedIn or Twitter.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.